---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-23-000028"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2023-07-03T23:59:59+00:00"
generated_at: "2026-06-13T13:11:25.303334+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HealthEquity CFO Tyson Murdock to depart after Aug 2023 10-Q filing; receives $100k retention bonus

## Summary
- CFO Tyson Murdock will cease as CFO following filing of Q2 FY2024 10-Q, expected in early September 2023.
- Murdock receives a $100,000 retention bonus for staying through filing date and assisting with 10-Q.
- After filing, Murdock may serve as Special Advisor to CEO until November 30, 2023, for transition.
- Termination is without cause; Murdock eligible for previously negotiated severance benefits.
- No successor CFO named; a new CFO will be appointed after transition period.

## SEC filing metadata
- accession: 0001428336-23-000028
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2023-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/0001428336-23-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/hqy-20230630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-23-000028
- JSON: https://secwatch.observer/filing/0001428336-23-000028.json
- Plain text: https://secwatch.observer/filing/0001428336-23-000028.txt

## Key facts
- Executive change
  Tyson Murdock departed as Chief Financial Officer at HEALTHEQUITY, INC..
  - Action: will cease serving as
  - Role: Chief Financial Officer
  source text: Tyson Murdock will cease serving as Chief Financial Officer following the filing of the Company’s Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal quarter ending July 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/0001428336-23-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.